CST 0.00% $3.77 cellestis limited

The company replies

  1. 4,086 Posts.
    G'day all,

    A couple of days ago some confusion arose from an article originating from the BBC, repeated by the ABC and then posted here on HotCopper. The article discussed a method for testing tb by analysing it's DNA.

    We discussed the item here and suggested that the DNA test was NOT, in fact, competition to the Cellestis Quantiferon TB test.

    The company has now replied. See the company reply here.

    The text of the reply follows:

    British DNA test is not a competitor to QuantiFERON-TB
    Recent news reports have drawn attention to work on a TB test from a British group from the
    University of Leicester, and Cellestis has received several enquiries asking how this affects our
    QuantiFERON-TB product and its prospects.
    The short answer is that there is no competition between the tests.
    QuantiFERON-TB tests the immune response of people to see if they are infected with
    tuberculosis, and is mostly used in latently infected people. These are individuals who are
    infected with tuberculosis but have not developed active TB disease. Latently infected people are
    not infectious themselves, but a proportion develops active TB disease and then passes the
    disease onto others.
    The Leicester test examines DNA taken from people with active TB disease and rapidly types the
    strain of bacteria to assist in epidemiological evaluation of the outbreak of active TB.
    Thus there is no competition between the tests, and each has a complementary role in TB
    control.
    Cellestis 12 Sept 2002

 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.